References

Cancer information / Diagnosis and treatment / Managing side effects / Hypercalcemia

Fojo AT. Metabolic emergencies. DeVita VT Jr, Lawrence TS, & Rosenberg SA. (2011). Cancer: Principles & Practice of Oncology. (9th Edition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 146: pp. 2142 - 2152.

Health Canada. (2015, October 19). Regulatory Decision Summary: Xgeva. Retrieved from: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/rds-sdr/drug-med/rds-sdr-xgeva-176891-eng.php.

Hemphill RR. Hypercalcemia in emergency medicine. (2013, April 23). eMedicine.Medscape.com. WebMD LLC.

Kaplan M. Hypercalcemia of malignancy. Kaplan M (Ed.). (2013). Understanding and Managing Oncologic Emergencies. (2nd Edition). Pittsburgh: Oncology Nursing Society. 4: pp. 103 - 155.

Lewis JL. Hypercalcemia. Beers, M. H., & Berkow, R., (Eds.). (2013, March). Merck Manual for Healthcare Professionals. Rahway, NJ: Merck Research Laboratories.

National Cancer Institute. (2012, November 9). Hypercalcemia (PDQ®) Patient Version. Bethesda, MD: National Cancer Institute.

Topiwala S. Hypercalcemia. National Cancer Institute & National Library of Medicine. (2012, March 22). MedlinePlus Medical Encyclopedia. Bethesda, MD: National Cancer Institute & National Library of Medicine.

Yeh HS, Berenson JR. Hypercalcemia. Berger AM, Shuster JL Jr, & Von Roenn JH (eds.). (2013). Principles and Practice of Palliative Care and Supportive Oncology. (4th Edition). Philadelphia: Lippincott Williams & Wilkins. 35: pp. 472 - 480.

×
×